NeuroPace Inc (NPCE)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, NeuroPace Inc reported revenue of $99.99M, up 25.1% from the prior year. The company ran a net loss, with a net margin of -21.5% and a gross margin of 77.2%. It held $105.56M in total assets against $86.53M in total liabilities.
Key ratios (FY2025)
77.2%
Gross margin
-16.3%
Operating margin
-21.5%
Net margin
-112.8%
Return on equity
+25.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $99.99M | $79.91M | $65.42M | $45.52M | $45.18M | $41.14M | — |
| Cost of Revenue | $22.77M | $20.82M | $17.30M | $13.03M | $11.75M | $10.87M | — |
| Gross Profit | $77.22M | $59.09M | $48.12M | $32.49M | $33.44M | $30.27M | — |
| Operating Income | -$16.34M | -$21.67M | -$27.17M | -$40.79M | -$23.74M | -$13.05M | — |
| Net Income | -$21.46M | -$27.14M | -$32.96M | -$47.08M | -$36.08M | -$24.28M | — |
| EPS (Diluted) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | $-117.85 | — |
| Total Assets | $105.56M | $94.65M | $107.65M | $114.11M | $133.56M | $55.95M | — |
| Total Liabilities | $86.53M | $86.63M | $87.00M | $79.33M | $60.06M | $62.36M | — |
| Shareholders' Equity | $19.03M | $8.01M | $20.65M | $34.78M | $73.50M | -$147.83M | -$129.35M |
| Cash & Equivalents | $21.69M | $13.43M | $18.06M | $6.61M | $19.19M | $26.39M | — |
| Operating Cash Flow | -$11.01M | -$17.95M | -$19.70M | -$36.87M | -$24.58M | -$21.61M | — |
| Capital Expenditures | $332.0K | $306.0K | $173.0K | $603.0K | $384.0K | $62.0K | — |
| Shares Outstanding | 33.57M | 30.15M | 27.82M | 25.05M | 24.45M | 314.1K | — |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | — | — | — | — |